Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Commentary & Opinion

Pharmaceutical Companies Should "Get on Board" With Unitaid's "Patent Pools"

October 5, 2011

In this Guardian opinion piece, Jill Filipovic, a freelance writer and blogger at Feministe, reports on how Unitaid, an organization "largely funded through innovating financing methods, including a tax on airplane tickets," is working to increase access to HIV/AIDS, malaria and tuberculosis treatments in developing countries through "patent pools" and urges pharmaceutical companies to "get on board."

"Unitaid ... is pushing pharmaceutical companies to sign on to 'patent pools,' where they suspend the patents on the most necessary HIV/AIDS drugs only for the poorest countries, allowing those drugs to be produced generically and combined with other companies' drugs," she writes, adding that Gilead Sciences has signed on to the plan. "The idea behind the patent pool is that everyone wins. People in developing countries who need drugs (and particularly second- and third-line treatments) get them on the cheap. ... The drug companies would be awarded royalties, and would maintain the patents in wealthier nations. ... It's a fairly simple moral calculus, but it remains to be seen if other big pharma companies will follow suit," she concludes (10/4).

Back to other news for October 2011


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More on HIV Drug Patent Policies

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement